These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753 [TBL] [Abstract][Full Text] [Related]
23. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC; Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631 [TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257 [TBL] [Abstract][Full Text] [Related]
25. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S; Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639 [TBL] [Abstract][Full Text] [Related]
26. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Page VJ; Ely EW; Gates S; Zhao XB; Alce T; Shintani A; Jackson J; Perkins GD; McAuley DF Lancet Respir Med; 2013 Sep; 1(7):515-23. PubMed ID: 24461612 [TBL] [Abstract][Full Text] [Related]
27. Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial. Richard JC; Terzi N; Yonis H; Chorfa F; Wallet F; Dupuis C; Argaud L; Delannoy B; Thiery G; Pommier C; Abraham P; Muller M; Sigaud F; Rigault G; Joffredo E; Mezidi M; Souweine B; Baboi L; Serrier H; Rabilloud M; Bitker L; Lancet Respir Med; 2023 Nov; 11(11):991-1002. PubMed ID: 37453445 [TBL] [Abstract][Full Text] [Related]
28. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. ; Truwit JD; Bernard GR; Steingrub J; Matthay MA; Liu KD; Albertson TE; Brower RG; Shanholtz C; Rock P; Douglas IS; deBoisblanc BP; Hough CL; Hite RD; Thompson BT N Engl J Med; 2014 Jun; 370(23):2191-200. PubMed ID: 24835849 [TBL] [Abstract][Full Text] [Related]
37. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Su X; Meng ZT; Wu XH; Cui F; Li HL; Wang DX; Zhu X; Zhu SN; Maze M; Ma D Lancet; 2016 Oct; 388(10054):1893-1902. PubMed ID: 27542303 [TBL] [Abstract][Full Text] [Related]
38. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Tongyoo S; Permpikul C; Mongkolpun W; Vattanavanit V; Udompanturak S; Kocak M; Meduri GU Crit Care; 2016 Oct; 20(1):329. PubMed ID: 27741949 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial. Bellingan G; Brealey D; Mancebo J; Mercat A; Patroniti N; Pettilä V; Quintel M; Vincent JL; Maksimow M; Jalkanen M; Piippo I; Ranieri VM Trials; 2017 Nov; 18(1):536. PubMed ID: 29132404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]